Expecting Growth in 2026 Families are not just receiving results - they are gaining the confidence and capability to ...

SickKids is providing the C-GUIDE™ tool evaluation of iHope's genomic testing for the diagnosis, care, and well-being ...

To mark the launch, Volta Labs and Watchmaker Genomics will host a joint in suite presentation at AGBT 2026 on February 24 at 8:30 a.m. in the Fulton Suite, where attendees can learn more about the ...

Ultima Genomics, a developer of an innovative, ultra-high throughput sequencing architecture, today announced the appointment of Elena Helman, PhD, as Vice President of Oncology Solutions. In this ...

CAMBRIDGE, England & SAN DIEGO, February 23, 2026--biomodal, an omics-based life sciences technology and analytics company, today announced at the AGBT 2026 General Meeting that biomodal’s duet ...

Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced that the Aventa™ Lymphoma test ...

Genomic medicine has the potential to impact all areas of medicine and change clinical practice. In contrast to the trial-and-error of today’s practice, genomic ...

Findings from the pilot phase of an ONC research program informed an independent set of interoperability standards for genomic data sharing, three ONC officials wrote in a Nov. 28 agency blog post.

A new survey-based Genomics Tracker focused on the EU-5 (France, Germany, Italy, Spain, and the United Kingdom) by DeciBio Consulting LLC provides updated insight into how genomics technologies are ...

Bridgewater, N.J.-based Clinical Genomics launched Colvera, a blood-based test for colorectal cancer recurrence monitoring. Here’s what you need to know. 1. Colvera is a qualitative test that ...

This article is authored by Ameera Shah, promoter and executive chairperson, Metropolis Healthcare Ltd.